Beyond Air (XAIR) Amortization of Deferred Charges (2016 - 2026)
Beyond Air (XAIR) reported Amortization of Deferred Charges of $100000.0 for Q1 2026, down 86.82% on a YoY basis from $759000.0 in Q1 2025, and down 21.88% sequentially from $128000.0 in Q4 2025.
Beyond Air (XAIR) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Beyond Air (XAIR) has 10 years of Amortization of Deferred Charges data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 86.82% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $445000.0 (down 56.71% YoY), and the FY2026 full-year result was $398000.0, down 61.28% from the prior year.
- Amortization of Deferred Charges slipped to $100000.0 in Q1 2026, from $128000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $759000.0 in Q1 2025 to a low of -$509000.0 in Q4 2024.
- A 5-year average of $177882.4 and a median of $99000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges surged 456.25% in 2022 and tumbled 239.07% in 2024, its largest moves.
- Tracing XAIR's Amortization of Deferred Charges over 5 years: stood at $99000.0 in 2022, then surged by 269.7% to $366000.0 in 2023, then plunged by 239.07% to -$509000.0 in 2024, then jumped by 125.15% to $128000.0 in 2025, then fell by 21.88% to $100000.0 in 2026.
- Business Quant data shows XAIR's Amortization of Deferred Charges at $100000.0 in Q1 2026, $128000.0 in Q4 2025, and $96000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Beyond Air | 2.23 Mn | -10.13 Mn | 94,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 128,000.00 |
| Dec 31, 2025 | 128,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 121,000.00 |
| Mar 31, 2025 | 759,000.00 |
| Mar 31, 2025 | 759,000.00 |
| Dec 31, 2024 | -509,000.00 |
| Dec 31, 2024 | -509,000.00 |
| Sep 30, 2024 | 684,000.00 |
| Sep 30, 2024 | 684,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | 366,000.00 |
| Dec 31, 2023 | 366,000.00 |